No-Spa (Drotaverine Hydrochloride)

Drotaverine Hydrochloride, the active ingredient in No-Spa, is a phosphodiesterase‑4 inhibitor presented as an oral tablet for oral use. It relaxes smooth muscle in the gastrointestinal, biliary and urinary tracts and is used to relieve spasmodic pain in adults. No-Spa is available over‑the‑counter in the European market and is supplied without a prescription.

GNH USA supplies No-Spa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

No-Spa (drotaverine) acts on smooth‑muscle spasm disorders in the gastrointestinal, biliary and urinary systems. It is indicated for: - Abdominal and gastrointestinal spasm: Relieves painful contractions of the intestinal wall. - Dysmenorrhea: Reduces uterine muscle cramps associated with menstrual pain. - Biliary colic: Alleviates spasm of the biliary ducts causing upper‑right abdominal discomfort. - Urinary tract spasm: Eases bladder and ureteral smooth‑muscle contractions. - Renal colic: Mitigates kidney‑related smooth‑muscle pain.

Adverse reactions may occur with any medication. Common Side Effects: - Dry mouth: Reduced salivary secretion. - Dizziness: Transient light‑headedness. - Headache: Mild to moderate pain. - Nausea: Stomach discomfort. - Flushing: Warm sensation of the skin. - Hypotension: Slight drop in blood pressure.

Serious or Rare Side Effects: - Allergic reaction: Rash, itching, swelling. - Severe hypotension: Marked blood pressure fall. - Tachycardia: Rapid heart rate. - Hepatic dysfunction: Elevated liver enzymes. - Blood dyscrasias: Unusual bleeding or bruising. - Anaphylaxis: Life‑threatening systemic reaction.

Before using No‑Spa, consider the following safety points. - Pregnancy: Use only if clearly needed, as safety data are limited. - Breastfeeding: Weigh potential benefits against unknown infant exposure. - Cardiovascular disease: Monitor blood pressure and heart rate. - Liver impairment: Use with caution; dose adjustment may be required. - Elderly patients: Start with the lowest effective dose and observe tolerance. - Store at ambient temperature: Keep below 25 °C, in the original packaging, protected from moisture.

Drug interactions may modify the effect of No‑Spa. Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): May increase drotaverine plasma levels. - Other antispasmodics: Additive smooth‑muscle relaxation can cause excessive hypotension. - Antihypertensive agents: Potential for enhanced blood‑pressure lowering. Moderate Interactions (Monitor Closely): - Alcohol: May intensify dizziness and hypotension. - Central nervous system depressants: Observe for increased sedation. - Diuretics: Monitor electrolyte balance and blood pressure.